Comorbidity and frailty assessment in renal cell carcinoma patients.

Jean CourcierAlexandre De La TailleNathalie LassauAlexandre Ingels

Published in: World journal of urology (2021)

Comorbidity and frailty have to be assessed at any stage of the RCC disease based on a standardized scoring system to define the most suitable treatment strategy ranging from surveillance to aggressive treatment.

Keyphrases

renal cell carcinoma
end stage renal disease
chronic kidney disease
newly diagnosed
peritoneal dialysis
smoking cessation
patient reported